Pain is common among patients with IIMs and is linked to worse physical function, increased fatigue, and reduced quality of life.

As such, they are orienting the RESET-Myositis trial to focus on two cohorts of patients: those with dermatomyositis or antisynthetase syndrome, and those with immune-mediated necrotizing myopathy.

Results of two phase 2 studies suggest efgartigimod could be a potential treatment for myositis and Sjögren disease in ...

June 11, 2025, 12:01 AM CET. Amsterdam, the Netherlands– argenx SE, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today ...

Clinically meaningful drug-free responses were observed in 3 of 4 refractory patients with immune-mediated necrotizing myopathy (IMNM), which are consistent with published data.

Necrotizing Fasciitis: Pathophysiology and Treatment Anne Fink; Gail DeLuca Disclosures Dermatology Nursing. 2002;14 (5) Psychological Issues ...

PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell ...

Theme Using Novel Techniques for Health Education and Communication Poster Session Congratulations to our poster session winners in each category! Clinical Vignette Category Winner A Unique Cause of ...

Editorial Archive Alcoholic Myopathy Published June 9, 1966 N Engl J Med 1966;274: 1326 - 1327 ...

Necrotizing fasciitis is a rapidly progressive soft-tissue infection characterized by necrosis of subcutaneous tissue. The usual causative organisms are group A β-hemolytic Streptococcus and ...

Objective To elucidate the common and distinct clinical features of immune-mediated necrotising myopathy (IMNM), also known as necrotising autoimmune myopathy associated with autoantibodies against ...